MORGAN STANLEY PLC/PUT/STRYKER CORP./300/0.1/19.12.25 Stock

Warrant

DE000MG10E69

Market Closed - Börse Stuttgart 12:08:23 2024-06-28 pm EDT
1.82 EUR +2.82% Intraday chart for MORGAN STANLEY PLC/PUT/STRYKER CORP./300/0.1/19.12.25
1 month+2.25%
3 months-4.21%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-28 1.82 +2.82%
24-06-27 1.77 -2.21%
24-06-26 1.81 -1.63%
24-06-25 1.84 +0.55%
24-06-24 1.83 +0.55%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 12:08 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MG10E6
ISINDE000MG10E69
Date issued 2024-03-28
Strike 300 $
Maturity 2025-12-19 (538 Days)
Parity 10 : 1
Emission price 1.69
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.48
Lowest since issue 1.53
Spread 0.04
Spread %2.17%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.2 USD
Average target price
372.9 USD
Spread / Average Target
+9.61%
Consensus